Fulin Liu | Cardiology | Best Researcher Award

Posted on by Pencis

Prof. Fulin Liu | Cardiology | Best Researcher Award

Prof. Fulin Liu, Affiliated Hospital of Hebei University , China

Prof. Fulin Liu is a distinguished researcher and cardiac surgeon affiliated with the Affiliated Hospital of Hebei University, where he has worked since 1988. He holds a degree from Hebei Medical University and has made significant contributions to cardiovascular health, particularly in myocardial ischemia-reperfusion injury and the therapeutic effects of hydrogen-rich water. Liu has authored numerous high-impact journal articles, with recent work focusing on mitochondrial function, glioma research, and innovative healthcare solutions. His research is widely recognized in leading medical journals, underscoring his global impact and ongoing commitment to advancing medical science and patient care.

Author Profile:

šŸŽ“Ā Education:

Prof. Fulin Liu completed his undergraduate education at Hebei Medical University in Shijiazhuang City, Hebei, China. He attended the university from September 1983 to June 1988, where he received a medical degree, which laid the foundation for his career in cardiac surgery and medical research. This academic background has been pivotal in shaping his research focus, particularly in the fields of cardiovascular health, ischemia-reperfusion injury, and the application of hydrogen-rich water in medical treatments. Liuā€™s educational experiences at Hebei Medical University have significantly influenced his innovative contributions to healthcare and medical science.

šŸ’¼ ProfessionalĀ Experience:

Prof. Fulin Liu has extensive professional experience in both clinical and research settings. Since 1988, he has been a cardiac surgeon at the Affiliated Hospital of Hebei University, where he has developed expertise in treating cardiovascular conditions, particularly myocardial ischemia-reperfusion injury. In addition to his clinical role, Liu has made significant contributions to medical research, publishing numerous articles on topics such as hydrogen-rich water, mitochondrial function, and glioma. His work bridges the gap between clinical practice and scientific discovery, advancing both patient care and medical knowledge. Liuā€™s career reflects a dedicated commitment to improving cardiovascular health and innovative therapies.

šŸŒResearch Contributions:

Prof. Fulin Liu’s research contributions focus primarily on cardiovascular health, particularly myocardial ischemia-reperfusion injury and the protective effects of hydrogen-rich water. His studies have revealed critical insights into mitochondrial function and its role in heart disease, with a focus on improving therapeutic strategies. Liu has also made notable contributions to the understanding of gliomas, including the role of circular RNAs and N6-methyladenosine modifications in tumor progression. His work extends to advanced healthcare technologies, such as knowledge graphs and mobile computing in medical applications. Through his numerous published articles, Liu continues to drive innovative research with significant clinical and therapeutic implications.

šŸ„‡Award and Honors:

Prof. Fulin Liu has received numerous awards and honors throughout his distinguished career, recognizing his contributions to the field of cardiac surgery and medical research. His groundbreaking work on myocardial ischemia-reperfusion injury, hydrogen-rich waterā€™s therapeutic effects, and his studies on gliomas have earned him widespread acclaim in the scientific community. Liuā€™s research has been published in top-tier medical journals, and his expertise has garnered international recognition. His dedication to advancing both clinical practices and scientific understanding has established him as a leader in his field, earning him significant accolades and reinforcing his reputation as a pioneering researcher.

Conclusion:

Prof. Fulin Liu’s extensive research and clinical expertise have made him a prominent figure in the field of cardiac surgery and biomedical research. His work on myocardial ischemia-reperfusion injury, hydrogen-rich water, and its therapeutic potential highlights his commitment to advancing cardiovascular medicine. Liuā€™s contributions to the understanding of molecular mechanisms in diseases like glioma further underscore his multidisciplinary approach to health research. With a remarkable publication record and ongoing involvement in clinical practice, Liuā€™s impact on both academic and medical communities is profound, establishing him as a leading figure in his field.

šŸ“šPublication Top Notes:

Hydrogen Protects Mitochondrial Function by Increasing the Expression of PGC-1Ī± and Ameliorating Myocardial Ischaemiaā€“Reperfusion Injury
Journal of Cellular and Molecular Medicine, 2024
šŸ“– Citations: 0
[DOI: 10.1111/jcmm.70236]

Spatiotemporal lipidomics reveals key features of brain lipid dynamic changes after cerebral ischemia and reperfusion therapy
Pharmacological Research, 2022
šŸ§  Citations: 15
[DOI: 10.1016/j.phrs.2022.106482]

Identification and characterization of N6-methyladenosine modification of circRNAs in glioblastoma
Journal of Cellular and Molecular Medicine, 2021
šŸ”¬ Citations: 8
[DOI: 10.1111/jcmm.16750]

Multitask Healthcare Management Recommendation System Leveraging Knowledge Graph
Journal of Healthcare Engineering, 2021
šŸ’” Citations: 19
[DOI: 10.1155/2021/1233483]

Medical Knowledge Graph in Chinese Using Deep Semantic Mobile Computation Based on IoT and WoT
Wireless Communications and Mobile Computing, 2021
šŸŒ Citations: 6
[DOI: 10.1155/2021/5590754]

M6A modification in RNA: Biogenesis, functions and roles in gliomas
Journal of Experimental and Clinical Cancer Research, 2020
šŸ§¬ Citations: 117
[DOI: 10.1186/s13046-020-01706-8]

Metabolomics Analysis of the Effect of Hydrogen-Rich Water on Myocardial Ischemia-Reperfusion Injury in Rats
Journal of Bioenergetics and Biomembranes, 2020
šŸ’§ Citations: 6
[DOI: 10.1007/s10863-020-09835-7]

Advances in circular RNAs and their role in glioma (Review)
International Journal of Oncology, 2020
šŸ”„ Citations: 26
[DOI: 10.3892/ijo.2020.5049]

New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
Biomedicine and Pharmacotherapy, 2020
šŸ¦  Citations: 222
[DOI: 10.1016/j.biopha.2020.110195]

Pressurizing and Stretching Experiment in Arterialized Veins of Rabbits
Yiyong Shengwu Lixue/Journal of Medical Biomechanics, 2020
šŸ‡ Citations: Not available
[DOI: 10.3969/j.issn.1005-8936.2020.02.006]

Yu Tian | Cardiac immunology | Best Researcher Award

Posted on by Pencis
Dr. Yu Tian, Jiangsu University, China

Dr. Yu Tian is a prominent researcher at Jiangsu University, China, specializing in immunology and molecular biology. With a focus on immune cell migration, viral myocarditis, and neuroinflammation, Dr. Tian has contributed significantly to understanding immune responses in cardiovascular and neurological diseases. He has published numerous articles in prestigious journals such as Journal of Leukocyte Biology and International Immunopharmacology, and his research explores therapeutic targets like HMGB1 and IL-22. Dr. Tian’s work plays a critical role in advancing treatment strategies for diseases involving immune system dysfunction and inflammation.

Profile:
Education:

 

Dr. Yu Tian completed his Bachelor’s Degree in Medicine at Qinghai University from September 2011 to June 2016. He then pursued his Master’s and Ph.D. at Jiangsu University, School of Medicine, from September 2016 to September 2022, where he specialized in immunology and molecular biology. His academic journey has laid a strong foundation for his research in immune cell function and disease mechanisms, contributing to his current role as a researcher at Jiangsu University.

Professional Experience:

 

Dr. Yu Tian is currently a researcher at Jiangsu University, School of Life Sciences, specifically within the International Genomics Research Center, a position he has held since December 2022. In this role, he leads a horizontal research project investigating the effects of HMGB1 on immune cells, which commenced in 2023. Additionally, Dr. Tian is actively involved in a National Natural Science Foundation of China (NSFC)-funded project that examines the role of IGF-1 in heart damage following myocardial infarction, scheduled for 2025 to 2027. His work contributes significantly to advancing the understanding of immune mechanisms in cardiovascular health.

 

Research Interest:

 

Dr. Yu Tian’s research interests lie in immunology, specifically investigating the role of HMGB1 in immune cell responses. He focuses on cardiovascular diseases, exploring the mechanisms that contribute to heart damage and myocardial infarction. Additionally, Dr. Tian studies adipose tissue accumulation and its impact on worsening heart conditions, aiming to uncover potential therapeutic targets for improving cardiovascular health. His work seeks to enhance the understanding of immune and metabolic interactions in the context of heart disease.

Conclusion:

Dr. Yu Tian is an accomplished researcher at Jiangsu University, specializing in immunology and cardiovascular diseases. With a solid educational background and a focus on the role of HMGB1 in immune responses, he is dedicated to unraveling the complex mechanisms underlying heart damage and myocardial infarction. His ongoing research projects aim to deepen the understanding of immune cell interactions and metabolic factors that exacerbate cardiovascular conditions. Through his contributions, Dr. Tian is poised to make a significant impact on the field, advancing potential therapeutic strategies for improving heart health and addressing related diseases.

Top Notable Publications:

Yin, P., Su, Z., Shu, X., Dong, Z., Tian, Y. (2024). Role of TREM2 in immune and neurological diseases: Structure, function, and implications. International Immunopharmacology, 143, 113286. 0 citations

Tian, Y., Gong, X., Qin, D., Liu, F., Su, Z. (2023). S1PR1-dependent migration of ILC3s from intestinal tissue to the heart in a mouse model of viral myocarditis. Journal of Leukocyte Biology, 114(2), 154ā€“163. 7 citations

Tian, Y., Chen, R., Su, Z. (2023). HMGB1 is a Potential and Challenging Therapeutic Target for Parkinsonā€™s Disease. Cellular and Molecular Neurobiology, 43(1), 47ā€“58. 6 citations

Chen, R., Liu, F., Xia, L., Xu, H., Su, Z. (2022). B10 cells decrease fibrosis progression following cardiac injury partially by IL-10 production and regulating hyaluronan secretion. Journal of Leukocyte Biology, 111(2), 415ā€“425. 1 citation

Cao, Y., Tian, Y., Liu, Y., Su, Z. (2022). Reg3Ī²: A Potential Therapeutic Target for Tissue Injury and Inflammation-Associated Disorders. International Reviews of Immunology, 41(2), 160ā€“170. 2 citations

Che, Y., Tian, Y., Chen, R., Liu, F., Su, Z. (2021). IL-22 ameliorated cardiomyocyte apoptosis in cardiac ischemia/reperfusion injury by blocking mitochondrial membrane potential decrease, inhibiting ROS and cytochrome C. Biochimica et Biophysica Acta – Molecular Basis of Disease, 1867(9), 166171. 26 citations

Chen, W., Yao, S., Wan, J., Yao, Y., Zhang, X. (2021). BBB-crossing adeno-associated virus vector: An excellent gene delivery tool for CNS disease treatment. Journal of Controlled Release, 333, 129ā€“138. 45 citations

Li, J., Xia, L., Liu, F., Chen, R., Su, Z. (2021). lncRNA187415.1 silence in BCAMs ameliorated breast cancer progression by blocking C/EBPĪ²-lncRNA187415.1-CISH axis and reversing pro-tumor characteristic of BCAMs. Clinical and Translational Medicine, 11(5), e407. 1 citation

Huang, L., Wan, J., Wu, Y., Su, Z., Xu, H. (2021). Challenges in adeno-associated virus-based treatment of central nervous system diseases through systemic injection. Life Sciences, 270, 119142. 26 citations

Wan, J., Wu, Y., Huang, L., Wang, S., Xu, H. (2021). ILC2-derived IL-9 inhibits colorectal cancer progression by activating CD8+ T cells. Cancer Letters, 502, 34ā€“43. 31 citations

 

 

Abdirahman Ali | Interventional Cardiology | Best Researcher Award

Posted on by Pencis

Dr. Abdirahman Ali | Interventional Cardiology | Best Researcher AwardĀ 

Dr. Abdirahman Ali, Doctor of family physician, Somalia

Dr.Ā  Abdirahman Ali is a dedicated family physician from Somalia, specializing in comprehensive healthcare for individuals and families. With a strong focus on preventive medicine, patient education, and holistic treatment, Dr. Ali is committed to improving community health outcomes. His expertise spans various aspects of family medicine, ensuring personalized care and attention to diverse patient needs. Dr. Ali continues to contribute to the healthcare field in Somalia, working to advance medical practices and provide accessible healthcare solutions for all.

Profile:
Scopus ProfileĀ 
OrcidĀ  profile
Education:

Dr. Abdirahman Ali holds a Master of Science in Family Medicine (2019-2022) and is currently pursuing a Master of Science in Research and Data Analysis (2022-2024), both from Amoud University in Borama, Somalia. He also earned his Bachelor of Medicine, Bachelor of Surgery (MBBS) from the same institution in 2018. Dr. Ali combines his medical expertise with a strong focus on research and data analysis, playing a key role as a family physician and research analyst at Amoud University.

Work Experience:

Dr. Abdirahman Ali currently serves as a specialized doctor at Borama Regional Hospital, where he provides comprehensive family medicine services, achieving a 98% patient satisfaction rate. He has led significant research on the effects of climate change on community health, resulting in three peer-reviewed publications and policy changes. Additionally, Dr. Ali utilizes advanced data analysis tools, improving health outcome predictions by 20%, and collaborates with local universities and NGOs to strengthen community resilience to climate-related health challenges.

Top Notable Publications:

Prevalence and determinants of hypertension among adults in Somalia using Somalia demographic health survey data, SDHS 2020
Farih, O.A., Ali, A.O., Abokor, A.H., Egge, A.A.A., Muse, A.H.
Current Problems in Cardiology, 2024, 49(11), 102783.
DOI: [Unavailable]
Abstract: This article analyzes the prevalence and determinants of hypertension in Somali adults, utilizing the Somalia Demographic Health Survey (SDHS) data from 2020. The study identifies key factors contributing to high blood pressure in Somalia and offers policy recommendations based on the findings.

Incidental diagnosis of Brugada syndrome in a patient initially presenting with acute coronary syndrome in resource-limited settings: A case report
Said, A.I., Ali, A.O., Said, A.O., Abdillahi, M.A., Elmi, H.S.A.
Atencion Primaria Practica, 2024, 6(4), 100208.
DOI: [Unavailable]
Abstract: This case report highlights the incidental diagnosis of Brugada syndrome in a patient from a resource-limited setting, who initially presented with symptoms of acute coronary syndrome. The article emphasizes the challenges in diagnosing rare cardiac conditions in such environments.

Left temporal epilepsy unmasking tuberculoma in an immunocompetent adolescent: Case report
Said, A.I., Abdulahi, M., Ali, A.O., Walhad, S.A., Muse, A.H.
Atencion Primaria Practica, 2024, 6(2), 100198.
DOI: [Unavailable]
Abstract: This case report describes an immunocompetent adolescent diagnosed with left temporal epilepsy, which later revealed an underlying tuberculoma. The article discusses the diagnostic process and treatment approaches in resource-limited settings.